Literature DB >> 27542409

Mechanistic Basis of Glutaminase Activation: A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS.

Yunxing Li1, Jon W Erickson1, Clint A Stalnecker1, William P Katt2, Qingqiu Huang3, Richard A Cerione4, Sekar Ramachandran1.   

Abstract

Glutamine-derived carbon becomes available for anabolic biosynthesis in cancer cells via the hydrolysis of glutamine to glutamate, as catalyzed by GAC, a splice variant of kidney-type glutaminase (GLS). Thus, there is significant interest in understanding the regulation of GAC activity, with the suggestion being that higher order oligomerization is required for its activation. We used x-ray crystallography, together with site-directed mutagenesis, to determine the minimal enzymatic unit capable of robust catalytic activity. Mutagenesis of the helical interface between the two pairs of dimers comprising a GAC tetramer yielded a non-active, GAC dimer whose x-ray structure displays a stationary loop ("activation loop") essential for coupling the binding of allosteric activators like inorganic phosphate to catalytic activity. Further mutagenesis that removed constraints on the activation loop yielded a constitutively active dimer, providing clues regarding how the activation loop communicates with the active site, as well as with a peptide segment that serves as a "lid" to close off the active site following substrate binding. Our studies show that the formation of large GAC oligomers is not a pre-requisite for full enzymatic activity. They also offer a mechanism by which the binding of activators like inorganic phosphate enables the activation loop to communicate with the active site to ensure maximal rates of catalysis, and promotes the opening of the lid to achieve optimal product release. Moreover, these findings provide new insights into how other regulatory events might induce GAC activation within cancer cells.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  enzyme mechanism; glutaminase; metabolism; mutagenesis; protein structure

Mesh:

Substances:

Year:  2016        PMID: 27542409      PMCID: PMC5076503          DOI: 10.1074/jbc.M116.720268

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

3.  Correlation between activation and dimer formation of rat renal phosphate-dependent glutaminase.

Authors:  S Godfrey; T Kuhlenschmidt; P Curthoys
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

4.  Full-length human glutaminase in complex with an allosteric inhibitor.

Authors:  Byron DeLaBarre; Stefan Gross; Cheng Fang; Yi Gao; Abhishek Jha; Fan Jiang; Juanhua Song J; Wentao Wei; Jonathan B Hurov
Journal:  Biochemistry       Date:  2011-11-18       Impact factor: 3.162

5.  Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.

Authors:  Alexandre Cassago; Amanda P S Ferreira; Igor M Ferreira; Camila Fornezari; Emerson R M Gomes; Kai Su Greene; Humberto M Pereira; Richard C Garratt; Sandra M G Dias; Andre L B Ambrosio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

6.  Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.

Authors:  Charles J McDonald; Eric Acheff; Ryan Kennedy; Lynn Taylor; Norman P Curthoys
Journal:  Neurochem Int       Date:  2014-12-12       Impact factor: 3.921

7.  Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Authors:  Matt I Gross; Susan D Demo; Jennifer B Dennison; Lijing Chen; Tania Chernov-Rogan; Bindu Goyal; Julie R Janes; Guy J Laidig; Evan R Lewis; Jim Li; Andrew L Mackinnon; Francesco Parlati; Mirna L M Rodriguez; Peter J Shwonek; Eric B Sjogren; Timothy F Stanton; Taotao Wang; Jinfu Yang; Frances Zhao; Mark K Bennett
Journal:  Mol Cancer Ther       Date:  2014-02-12       Impact factor: 6.261

8.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Authors:  Yan Xiang; Zachary E Stine; Jinsong Xia; Yunqi Lu; Roddy S O'Connor; Brian J Altman; Annie L Hsieh; Arvin M Gouw; Ajit G Thomas; Ping Gao; Linchong Sun; Libing Song; Benedict Yan; Barbara S Slusher; Jingli Zhuo; London L Ooi; Caroline G L Lee; Anthony Mancuso; Andrew S McCallion; Anne Le; Michael C Milone; Stephen Rayport; Dean W Felsher; Chi V Dang
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 9.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

10.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).

Authors:  Mary M Robinson; Steven J McBryant; Takashi Tsukamoto; Camilo Rojas; Dana V Ferraris; Sean K Hamilton; Jeffrey C Hansen; Norman P Curthoys
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

View more
  11 in total

1.  Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.

Authors:  Qingqiu Huang; Clint Stalnecker; Chengliang Zhang; Lee A McDermott; Prema Iyer; Jason O'Neill; Shawn Reimer; Richard A Cerione; William P Katt
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

2.  Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators.

Authors:  Clint A Stalnecker; Jon W Erickson; Richard A Cerione
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

3.  The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.

Authors:  Yunxing Li; Sekar Ramachandran; Thuy-Tien T Nguyen; Clint A Stalnecker; Richard A Cerione; Jon W Erickson
Journal:  J Biol Chem       Date:  2019-12-23       Impact factor: 5.157

4.  GAC inhibitors with a 4-hydroxypiperidine spacer: Requirements for potency.

Authors:  Lee McDermott; David Koes; Shabber Mohammed; Prema Iyer; Melissa Boby; Venkatakrishnan Balasubramanian; Mackenzie Geedy; William Katt; Richard Cerione
Journal:  Bioorg Med Chem Lett       Date:  2019-08-20       Impact factor: 2.823

5.  SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.

Authors:  Kai Su Greene; Michael J Lukey; Xueying Wang; Bryant Blank; Joseph E Druso; Miao-Chong J Lin; Clint A Stalnecker; Chengliang Zhang; Yashira Negrón Abril; Jon W Erickson; Kristin F Wilson; Hening Lin; Robert S Weiss; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 6.  A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.

Authors:  William P Katt; Michael J Lukey; Richard A Cerione
Journal:  Future Med Chem       Date:  2017-01-23       Impact factor: 3.808

Review 7.  Metabolic Imaging of Glutamine in Cancer.

Authors:  Lin Zhu; Karl Ploessl; Rong Zhou; David Mankoff; Hank F Kung
Journal:  J Nucl Med       Date:  2017-02-23       Impact factor: 10.057

8.  Structure and activation mechanism of the human liver-type glutaminase GLS2.

Authors:  Igor M Ferreira; José Edwin N Quesñay; Alliny Cs Bastos; Camila T Rodrigues; Melanie Vollmar; Tobias Krojer; Claire Strain-Damerell; Nicola A Burgess-Brown; Frank von Delft; Wyatt W Yue; Sandra Mg Dias; Andre Lb Ambrosio
Journal:  Biochimie       Date:  2021-03-18       Impact factor: 4.079

Review 9.  Amino acid homeostasis and signalling in mammalian cells and organisms.

Authors:  Stefan Bröer; Angelika Bröer
Journal:  Biochem J       Date:  2017-05-25       Impact factor: 3.857

10.  Molecular Analysis of Bacterial Isolates From Necrotic Wheat Leaf Lesions Caused by Xanthomonas translucens, and Description of Three Putative Novel Species, Sphingomonas albertensis sp. nov., Pseudomonas triticumensis sp. nov. and Pseudomonas foliumensis sp. nov.

Authors:  James T Tambong; Renlin Xu; Suzanne Gerdis; Greg C Daniels; Denise Chabot; Keith Hubbard; Michael W Harding
Journal:  Front Microbiol       Date:  2021-05-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.